Literature DB >> 2665768

Implications of a Fab-like structure for the T-cell receptor.

J M Claverie, A Prochnicka-Chalufour, L Bougueleret.   

Abstract

The antigen-specific receptor of T lymphocytes (TCR) and the Fab moiety of immunoglobulins are expected to fold into similar three-dimensional structures because of their identical protein domain organization, the conservation of key residues and their overall sequence homology. However, T cells mostly appear to recognize short peptide antigens bound to MHC class I or class II presenting molecules. A complete model of the human leucocyte antigen molecule (HLA-A2) reconstructed from the alpha-carbon coordinates was used to investigate the putative organization of a TCR/peptide/HLA-A2 complex. In this article, Jean-Michel Claverie and co-workers show that the respective geometries of a Fab-like TCR structure and of the HLA-A2 antigen binding site suggest a model where the third variable regions of both chains of the TCR mainly interact with the peptide antigen, while the first and/or second less variable regions are in position for making contact with residues pointing up from the alpha 1 and alpha 2 helical regions of the HLA-A2 molecule.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2665768     DOI: 10.1016/0167-5699(89)90058-3

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  35 in total

1.  Similarity between fluorescein-specific T-cell receptor and antibody in chemical details of antigen recognition.

Authors:  R K Ganju; S T Smiley; J Bajorath; J Novotny; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

2.  T-cell antigen receptor binding sites for the microbial superantigen staphylococcal enterotoxin A.

Authors:  C H Pontzer; M J Irwin; N R Gascoigne; H M Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

3.  Resolution of hypervariable regions in T-cell receptor beta chains by a modified Wu-Kabat index of amino acid diversity.

Authors:  R Jores; P M Alzari; T Meo
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  The three-dimensional structure of a T-cell antigen receptor V alpha V beta heterodimer reveals a novel arrangement of the V beta domain.

Authors:  D Housset; G Mazza; C Grégoire; C Piras; B Malissen; J C Fontecilla-Camps
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

5.  Modulation of T cell responses with MHC-derived peptides.

Authors:  W V Williams; D B Weiner; M A Borofsky; D H Rubin; K Yui; M I Greene
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

6.  Profound alteration in an alpha beta T-cell antigen receptor repertoire due to polymorphism in the first complementarity-determining region of the beta chain.

Authors:  S J Gahm; B J Fowlkes; S C Jameson; N R Gascoigne; M M Cotterman; O Kanagawa; R H Schwartz; L A Matis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

7.  Direct binding of secreted T-cell receptor beta chain to superantigen associated with class II major histocompatibility complex protein.

Authors:  N R Gascoigne; K T Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

8.  Highly conserved T-cell receptor junctional regions. Evidence for selection at the protein and the DNA level.

Authors:  S B Sorger; S M Hedrick
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

9.  Characterization of diverse primary herpes simplex virus type 1 gB-specific cytotoxic T-cell response showing a preferential V beta bias.

Authors:  S C Cose; J M Kelly; F R Carbone
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  T-cell receptor beta-chain gene usage in the T-cell recognition of Mycobacterium leprae antigens in one tuberculoid leprosy patient.

Authors:  W C van Schooten; J L Ko; N van der Stoep; J B Haanen; L Pickering; R R de Vries; P van den Elsen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.